Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect?

Transfusion Clinique et Biologique

Volumn 19, Issue 3, 2012, Pages 90-97

  Saas, P ^a,b,c   Angelot, F ^a,b,c   Bardiaux, L ^a,b,c   Seilles, E ^a,b,c   Garnache Ottou, F ^a,b,c   Perruche, S ^a,b,c  

^a RIGHT Interactions Hôte Greffon Tumeur Ingénierie Cellulaire et Génique   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Apoptotic cells; Dendritic cells; Inflammation; Labile blood products; Macrophages; Microparticles; Tolerance; TRALI; Transfusion; Treg

Indexed keywords

BLOOD DERIVATIVE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHATIDYLSERINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; CD4+ T LYMPHOCYTE; CLONAL ANERGY; CRYOPRESERVATION; DENDRITIC CELL; ERYTHROCYTE PRESERVATION; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE MICROPARTICLE; MACROPHAGE; PLATELET MICROPARTICLE; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; THROMBOCYTE ACTIVATION; TRANSFUSION RELATED ACUTE LUNG INJURY;

BLOOD TRANSFUSION; CELL-DERIVED MICROPARTICLES; HUMANS; INFLAMMATION; PHOSPHATIDYLSERINES;

EID: 84864757331     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2012.02.002     Document Type: Article

References (78)

1. Ozier Y., Muller J.Y., Mertes P.M., Renaudier P., Aguilon P., Canivet N., et al. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion 2011, 51:2102-2110.
2. Shaz B.H., Stowell S.R., Hillyer C.D. Transfusion-related acute lung injury: from bedside to bench and back. Blood 2011, 117:1463-1471.
3. Eder A.F., Herron R., Strupp A., Dy B., Notari E.P., Chambers L.A., et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007, 47:599-607.
4. Sachs U.J. Recent insights into the mechanism of transfusion-related acute lung injury. Curr Opin Hematol 2011, 18:436-442.
5. Lee J.S., Gladwin M.T. Bad blood: the risks of red cell storage. Nat Med 2010, 16:381-382.
6. Vamvakas E.C., Blajchman M.A. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010, 24:77-124.
7. Vamvakas E.C. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996, 36:175-186.
8. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007, 21:327-348.
9. Opelz G., Vanrenterghem Y., Kirste G., Gray D.W., Horsburgh T., Lachance J.G., et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997, 63:964-967.
10. Flye M.W., Burton K., Mohanakumar T., Brennan D., Keller C., Goss J.A., et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995, 60:1395-1401.
11. Marti H.P., Henschkowski J., Laux G., Vogt B., Seiler C., Opelz G., et al. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Transpl Int 2006, 19:19-26.
12. Rumsby M.G., Trotter J., Allan D., Michell R.H. Recovery of membrane micro-vesicles from human erythrocytes stored for transfusion: a mechanism for the erythrocyte discocyte-to-spherocyte shape transformation. Biochem Soc Trans 1977, 5:126-128.
13. Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 1998, 74:189-200.
14. Frabetti F., Musiani D., Marini M., Fanelli C., Coppola S., Ghibelli L., et al. White cell apoptosis in packed red cells. Transfusion 1998, 38:1082-1089.
15. Martelli A.M., Tazzari P.L., Bortul R., Riccio M., Tabellini G., Santi S., et al. Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. Transfusion 2000, 40:169-177.
16. Li J., Xia Y., Bertino A.M., Coburn J.P., Kuter D.J. The mechanism of apoptosis in human platelets during storage. Transfusion 2000, 40:1320-1329.
17. Frabetti F., Tazzari P.L., Musiani D., Bontadini A., Matteini C., Roseti L., et al. White cell apoptosis in platelet concentrates. Transfusion 2000, 40:160-168.
18. Reid T.J., Esteban G., Clear M., Gorogias M. Platelet membrane integrity during storage and activation. Transfusion 1999, 39:616-624.
19. Bontadini A., Tazzari P.L., Manfroi S., Tassi C., Conte R. Apoptosis in leucodepleted packed red blood cells. Vox Sang 2002, 83:35-41.
20. Bertino A.M., Qi X.Q., Li J., Xia Y., Kuter D.J. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003, 43:857-866.
21. Perrotta P.L., Perrotta C.L., Snyder E.L. Apoptotic activity in stored human platelets. Transfusion 2003, 43:526-535.
22. Leytin V., Allen D.J., Mutlu A., Mykhaylov S., Lyubimov E., Freedman J. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. Br J Haematol 2008, 142:494-497.
23. Lawrie A.S., Harrison P., Cardigan R.A., Mackie I.J. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008, 95:197-204.
24. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. Red blood cells-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008, 48:1943-1953.
25. Rubin O., Crettaz D., Canellini G., Tissot J.D., Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008, 95:288-297.
26. Salzer U., Zhu R., Luten M., Isobe H., Pastushenko V., Perkmann T., et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008, 48:451-462.
27. Albanyan A.M., Harrison P., Murphy M.F. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days. Transfusion 2009, 49:108-117.
28. Antonelou M.H., Kriebardis A.G., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol. Transfusion 2010, 50:376-389.
29. Cookson P., Sutherland J., Turner C., Bashir S., Wiltshire M., Hancock V., et al. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution. Transfus Med 2010, 20:392-402.
30. Jy W., Horstman L.L., Ahn Y.S. Microparticle size and its relation to composition, functional activity, and clinical significance. Semin Thromb Hemost 2010, 36:876-880.
31. Sugawara A., Nollet K.E., Yajima K., Saito S., Ohto H. Preventing platelet-derived microparticle formation--and possible side effects-with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010, 134:771-775.
32. Xu Y., Nakane N., Maurer-Spurej E. Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 2011, 51:363-370.
33. Matijevic N., Wang Y.W., Kostousov V., Wade C.E., Vijayan K.V., Holcomb J.B. Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res 2011, 128:35-41.
34. Keating F.K., Butenas S., Fung M.K., Schneider D.J. Platelet-white blood cell (WBC) interaction? WBC apoptosis, and procoagulant activity in stored red blood cells. Transfusion 2011, 51:1086-1095.
35. Jy W., Ricci M., Shariatmadar S., Gomez-Marin O., Horstman L.H., Ahn Y.S. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011, 51:886-893.
36. Lawrie A.S., Albanyan A., Cardigan R.A., Mackie I.J., Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009, 96:206-212.
37. Jacobson M.D., Burne J.F., Raff M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. Embo J 1994, 13:1899-1910.
38. Dzik W.H., Apoptosis TGF beta and transfusion-related immunosuppression: biologic versus clinical effects. Transfus Apher Sci 2003, 29:127-129.
39. Snyder E.L., Kuter D.J. Apoptosis in transfusion medicine: of death and dying-is that all there is?. Transfusion 2000, 40:135-138.
40. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
41. Berckmans R.J., Nieuwland R., Boing A.N., Romijn F.P., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85:639-646.
42. Griffith T.S., Ferguson T.A. Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 2011, 35:456-466.
43. Saas P., Bonnefoy F., Kury-Paulin S., Kleinclauss F., Perruche S. Mediators involved in the immunomodulatory effects of apoptotic cells. Transplantation 2007, 84:S31-S34.
44. Saas P., Gaugler B., Perruche S. Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome. Ann N Y Acad Sci 2010, 1209:118-126.
45. Gregory C.D., Pound J.D. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol 2011, 223:177-194.
46. Ravichandran K.S. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 2011, 35:445-455.
47. Frey B., Gaipl U.S. The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol 2011, 33:497-516.
48. Stuart L.M., Lucas M., Simpson C., Lamb J., Savill J., Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 2002, 168:1627-1635.
49. Perruche S., Saas P., Chen W. Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy?. Arthritis Res Ther 2009, 11:R104.
50. Kleinclauss F., Perruche S., Masson E., de Carvalho Bittencourt M., Biichle S., Remy-Martin J.P., et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006, 13:41-52.
51. Perruche S., Zhang P., Liu Y., Saas P., Bluestone J.A., Chen W. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008, 14:528-535.
52. Bittencourt M.C., Perruche S., Contassot E., Fresnay S., Baron M.H., Angonin R., et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001, 98:224-230.
53. Bonnefoy F., Perruche S., Couturier M., Sedrati A., Sun Y., Tiberghien P., et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol 2011, 186:5696-5705.
54. Perruche S., Kleinclauss F., Bittencourt Mde C., Paris D., Tiberghien P., Saas P. Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 2004, 4:1361-1365.
55. Sun E., Gao Y., Chen J., Roberts A.I., Wang X., Chen Z., et al. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ 2004, 11:1258-1264.
56. Miyake Y., Asano K., Kaise H., Uemura M., Nakayama M., Tanaka M. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J Clin Invest 2007, 117:2268-2278.
57. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002, 109:41-50.
58. Bondanza A., Zimmermann V.S., Rovere-Querini P., Turnay J., Dumitriu I.E., Stach C.M., et al. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 2004, 200:1157-1165.
59. Asano K., Miwa M., Miwa K., Hanayama R., Nagase H., Nagata S., et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 2004, 200:459-467.
60. Dzik W.H., Mincheff M., Puppo F. An alternative mechanism for the immunosuppressive effect of transfusion. Vox Sang 2002, 83:417-419.
61. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
62. Jackson S.P., Schoenwaelder S.M. Procoagulant platelets: are they necrotic?. Blood 2010, 116:2011-2018.
63. Connor D.E., Exner T., Ma D.D., Joseph J.E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010, 103:1044-1052.
64. Tissot J.D., Rubin O., Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010, 17:571-577.
65. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104:2543-2548.
66. Koppler B., Cohen C., Schlondorff D., Mack M. Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory properties of microparticles. Eur J Immunol 2006, 36:648-660.
67. Eken C., Gasser O., Zenhaeusern G., Oehri I., Hess C., Schifferli J.A. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J Immunol 2008, 180:817-824.
68. Sadallah S., Eken C., Schifferli J.A. Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol 2008, 84:1316-1325.
69. Angelot F., Seilles E., Biichle S., Berda Y., Gaugler B., Plumas J., et al. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica 2009, 94:1502-1512.
70. Lima L.G., Chammas R., Monteiro R.Q., Moreira M.E., Barcinski M.A. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 2009, 283:168-175.
71. Eken C., Martin P.J., Sadallah S., Treves S., Schaller M., Schifferli J.A. Ectosomes released by polymorphonuclear neutrophils induce a MerTK-dependent anti-inflammatory pathway in macrophages. J Biol Chem 2010, 285:39914-39921.
72. Sadallah S., Eken C., Martin P.J., Schifferli J.A. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 2011, 186:6543-6552.
73. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010, 234:142-162.
74. Figueiredo R.T., Fernandez P.L., Mourao-Sa D.S., Porto B.N., Dutra F.F., Alves L.S., et al. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 2007, 282:20221-20229.
75. Pelletier F., Garnache-Ottou F., Angelot F., Biichle S., Vidal C., Humbert P., et al. Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. J Invest Dermatol 2011, 131:1573-1576.
76. Rettig L., Haen S.P., Bittermann A.G., von Boehmer L., Curioni A., Kramer S.D., et al. Particle size and activation threshold: a new dimension of danger signaling. Blood 2010, 115:4533-4541.
77. Franz S., Herrmann K., Furnrohr B.G., Sheriff A., Frey B., Gaipl U.S., et al. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ 2007, 14:733-742.
78. Fransen J.H., Hilbrands L.B., Ruben J., Stoffels M., Adema G.J., van der Vlag J., et al. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 2009, 60:2304-2313.